Scientists find natural mimetics of anti-cancer & anti-aging drugs metformin and rapamycin

Researchers from the Biogerontology Research Foundation, Insilico Medicine, Life Extension and other institutions announce the publication of a landmark study in the journal Aging on the identification of natural mimetics of metformin and rapamycin. Metformin, a common type 2 diabetes drug, and rapamycin, a common anti-rejection drug, have both been shown to have substantial anti-aging and anti-cancer effects in a variety of model organisms.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news